Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 2, 2011

PhyNexus and BAC Combine Technologies for Small-Volume Protein Purification

  • PhyNexus and BAC are together launching a range of BAC’s CaptureSelect® ligands in PhyNexus’ PhyTip® column format. They are designed for parallel processing in an automated format.

    The columns can be used with any of the manufacturer’s robotic liquid-handling platforms. Pure and highly concentrated samples obtained from the processing are ready for cell-based assays, analytics, or any desired functional test.

    In addition, PhyTip columns set up a matrix of purification conditions. This allows researchers to scout for the best purification conditions, resulting in high yield and activity.

    “BAC has created a unique and powerful platform for affinity purification with its range of CaptureSelect products,” comments Douglas Gjerde, Ph.D., CEO of PhyNexus, adding: “The availability of the CaptureSelect resins in the PhyTip column format provides additional flexibility to scientists who wish to determine the best purification conditions for their needs.”

    BAC CaptureSelect products are affinity ligands created by a technology based on Camelid-derived single domain antibody fragments. The ligand is a 12 kD single domain fragment which comprises the 3 CDRs that form the antigen binding domain, efficiently produced by the yeast Saccharomyces cerevisiae.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »